News | August 27, 2022
Jubilant receives EIR from USFDA for its radiopharmaceuticals manufacturing facility Montreal Canada
With the receipt of the EIR, the inspection stands successfully closed.
With the receipt of the EIR, the inspection stands successfully closed.
Desvenlafaxine Extended-Release Tablets, 25 mg is a generic equivalent of Pristiq Extended-Release Tablets, 25 mg of PF PRISM C.V.
99% of Pristyn Doctors are using EMR facility on its doctor app
The company has received 1 (ONE) observation on Form 483 with respect to ANDA filed for the product to be manufactured at the said Facility.
Formoterol Fumarate Inhalation Solution (RLD Perforomist) had estimated annual sales of US $282 million in the US
The funding round also saw participation from some of India's top angel investors and leading industry giants
The company continues to cooperate with the US FDA and is committed to undertake all necessary steps required to address their observations at the earliest
The approved product has an estimated market size of around US $62 million for the twelve months ending June 2022 according to IQVIA
Phase 2 Study of MK-2060 Currently Ongoing in People with End-Stage Renal Disease Receiving Hemodialysis
Today, India stands at 1.7 nurses per 1,000 population, as opposed to the World Health Organization norm of 3 nurses per 1000.
Subscribe To Our Newsletter & Stay Updated
